Denis Larsimont Selected Research

Phosphatidylinositol 3-Kinases (PI 3 Kinase)

1/2021

The genomic landscape of carcinomas with mucinous differentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Denis Larsimont Research Topics

Disease

72	Breast Neoplasms (Breast Cancer) 01/2024 - 05/2002
64	Neoplasms (Cancer) 01/2024 - 05/2002
9	Neoplasm Metastasis (Metastasis) 06/2020 - 10/2008
5	Triple Negative Breast Neoplasms 12/2023 - 01/2016
5	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 12/2005
4	Carcinoma (Carcinomatosis) 02/2023 - 10/2016
3	Pathologic Complete Response 01/2018 - 10/2013
3	Tertiary Lymphoid Structures 01/2018 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2016
2	Papillary Thyroid Cancer 01/2019 - 04/2015
2	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2017 - 08/2010
2	Disease Progression 01/2016 - 07/2015
1	Inflammatory Breast Neoplasms 12/2023
1	Pericarditis 12/2023
1	Carcinosarcoma 02/2023
1	Solitary Fibrous Tumors 10/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Ductal Carcinoma 01/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021
1	Margins of Excision 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 02/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Cicatrix (Scar) 02/2018

Drug/Important Bio-Agent (IBA)

16	Estrogen ReceptorsIBA 01/2023 - 03/2003
13	Biomarkers (Surrogate Marker)IBA 01/2024 - 03/2008
10	Phenobarbital (Luminal)FDA Link 12/2023 - 07/2005
9	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2024 - 01/2016
9	ParaffinIBA 08/2017 - 07/2002
8	AnthracyclinesIBA 08/2017 - 05/2002
7	Hormones (Hormone)IBA 09/2022 - 10/2005
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2002
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 12/2004
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2005
5	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2013
5	Trastuzumab (Herceptin)FDA Link 01/2018 - 10/2006
5	Tamoxifen FDA LinkGeneric 02/2016 - 12/2004
5	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2013 - 10/2004
4	durvalumabIBA 12/2023 - 08/2021
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 01/2016
4	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 10/2004
4	ErbB Receptors (EGF Receptor)IBA 09/2022 - 12/2005
4	Hematoxylin (Haematoxylon)IBA 01/2021 - 01/2017
4	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2017
4	Formaldehyde (Formol)FDA Link 08/2017 - 03/2008
4	Messenger RNA (mRNA)IBA 10/2013 - 12/2006
4	Docetaxel (Taxotere)FDA Link 05/2012 - 12/2002
3	Letrozole (Femara)FDA LinkGeneric 08/2022 - 02/2016
3	human ERBB2 proteinIBA 01/2018 - 12/2009
3	Epirubicin (Ellence)FDA LinkGeneric 10/2013 - 05/2002
3	trioctyl phosphine oxide (TOPO)IBA 12/2008 - 05/2002
2	taxaneIBA 12/2023 - 05/2012
2	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 11/2023
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 05/2002
2	Adenosine (Adenocard)FDA LinkGeneric 12/2023 - 08/2021
2	Circulating Tumor DNAIBA 09/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 08/2017
2	MucinsIBA 01/2021 - 01/2019
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 06/2009
2	Aromatase InhibitorsIBA 01/2021 - 06/2009
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2019
2	ChemokinesIBA 01/2019 - 07/2013
2	CytokinesIBA 01/2019 - 07/2013
2	AntigensIBA 01/2018 - 07/2002
2	Estrogens (Estrogen)FDA Link 01/2018 - 06/2009
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2016 - 08/2009
2	Peptide Hydrolases (Proteases)FDA Link 08/2010 - 12/2006
2	tau Proteins (tau Protein)IBA 07/2008 - 12/2002
2	TubulinIBA 07/2008 - 12/2002
1	LigandsIBA 12/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	CarbonIBA 01/2023
1	CollagenIBA 10/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2021
1	Denosumab FDA Link 12/2020
1	Indicators and Reagents (Reagents)IBA 06/2020
1	SirtuinsIBA 02/2020
1	atezolizumabIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Progesterone FDA LinkGeneric 01/2019
1	Pyruvate CarboxylaseIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 09/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2018
1	AntibodiesIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Cyclin D1IBA 01/2018
1	Differentiation AntigensIBA 01/2018

Therapy/Procedure

19	Therapeutics 01/2024 - 05/2002
10	Drug Therapy (Chemotherapy) 12/2023 - 07/2008
6	Neoadjuvant Therapy 12/2023 - 01/2013
5	Immunotherapy 11/2023 - 11/2017
4	Adjuvant Chemotherapy 08/2021 - 08/2014
3	Radiotherapy 12/2023 - 02/2020
3	Segmental Mastectomy (Lumpectomy) 10/2023 - 01/2021
2	Cytoreduction Surgical Procedures 02/2018 - 12/2016
1	Intravenous Injections 08/2020